De behandeling van Helicobacter pylori-infectie

Nederlands Tijdschrift voor Geneeskunde

Volumn 140, Issue 18, 1996, Pages 967-970

  Van Der Hulst, R W M ^a   Keller, J J ^a   Rauws, E A J ^a   Tytgat, G N J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTACID AGENT; ANTIBIOTIC AGENT; BISMUTH; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; TETRACYCLINE;

GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; REVIEW; STOMACH ULCER;

ADOLESCENT; ADULT; ANTACIDS; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BISMUTH; CHILD; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; HUMANS; MIDDLE AGED; OMEPRAZOLE; STOMACH ULCER;

EID: 0029943726     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis [letter]. Lancet 1983;i:1273-5.
2. Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust 1985;142:436-9.
3. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994;89 Suppl:S116-28.
4. Kuipers EJ, Peña AS, Kamp G van, Uyterlinde AM, Pals NFM, Kurz-Pohlman E, et al. Seroconversion for Helicobacter pylori. Lancet 1993;342:328-31.
5. Webb PM, Knight T, Greaves S, Wilson A, Newell DG, Elder J, et al. Relation between infection with Helicobacter pylori and living conditions in childhood: evidence for person to person transmission in early life. BMJ 1994;308:750-3.
6. Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 1995;9 Suppl:33-9.
7. Rauws EAJ, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GNJ. Campylobacter pyloridis-associated chronic antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterol 1988;94:33-40.
8. Hulst RWM van der, Tytgat GNJ. Helicobacter pylori and peptic ulcer disease. Scand J Gastroenterol [ter perse].
9. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
10. Talley NJ. A critique of therapeutic trials in Helicobacler pylori-positive functional dyspepsia. Gastroenterology 1994;106:1174-83.
11. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
12. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, et al. Heliobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-71.
13. Kuipers EJ, Uyterlinde AM, Peña AS, Roosendaal R, Pals G, Nelis GF, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525-28.
14. Bayerdorffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S. et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 1995;345:1591-4.
15. Chiba N, Rao BV, Rademaker JW, Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992;87:1716-27.
16. Hulst RWM van der, Keller JJ, Rauws EAJ, Tytgat GNJ. Treatment of Helicobacter pylori infection. Review of the world literature. Helicobacter 1996;1:6-19.
17. Borody TJ, Brandi S, Andrews P, Ferch N, Jankiewicz E, Hyland L. Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori. Am J Gastroenterol 1994;89:33-8.
18. Noach LA, Langenberg WL, Bertola MA, Dankert J, Tytgat GNJ. Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scand J Infect Dis 1994;26:321-7.
19. Axon ATR. The role of acid inhibition in the treatment of Helicobacter pylori infection. Scand J Gastroenterol 1994;29 Suppl 201:16-23.
20. Labenz J, Gyenes E, Ruhl GH, Borsch G, Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study. Gut 1993;34:1167-70.
21. Bayerdorffer E, Miehlke S, Mannes GA, Sommer A, Hochter W, Weingart J, et al. Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology 1995;108:1412-7.
22. Hulst RWM van der, Weel JFL Verheul SB, Keller JJ, Kate FJW ten, Ende AE van der, et al. Treatment of Helicobacter pylori infection with low or high dose omeprazole combined with amoxicillin and the effect of early retreatment: a prospective randomized double-blind study. Aliment Ther Pharmacol 1996;10:165-71.
23. Cayla R, Zerbib F, Megraud F, Lamouliatte H. Clarithromycin resistance of Helicobacter pylori strains before and after treatment: a key factor of treatment failures [abstract]. Gastroenterol 1995; 108:68.
24. Hentschel E, Brandstätter G, Dragosics B, Hirschl AM, Nemec H, Schutze K, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328:308-12.
25. Bazzoli F, Zagari RM, Fossi S, Pozzato P, Alampi G, Simoni P, et al. Short term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994;6:773-7.
26. Moayyedi P, Sahay P, Tompkins DS, Axon ATR. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regiment to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995; 7:835-40.
27. Boer W de, Driessen W, Jansz A, Tytgat G. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995;345:817-20.